latest news releases from the newsroom
Hemispherx Biopharma, Inc.
Hemispherx Biopharma Announces Licensing/Research Agreements On Ampligen as Influenza Adjuvant With Japan's BIKEN
PHILADELPHIA, Dec. 13, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has concluded an agreement with a major vaccine manufacturer in Japan for the use of the Company's experimental drug Ampligen(r) as an immune enhancer to influenza vaccines. The Company's agreement with BIKEN (the non-profit operational arm of the Foundation for Microbial Diseases of Osaka University) is part of a 3 party agreement to develop an effective influenza vaccine for Japan and utilizes vast resources of the National Institute of Infectious Diseases of Japan ("NIID").
Generex Biotechnology Corp.
Generex Biotechnology Receives $400,000 Purchase Order for OTC Products From Middle Eastern Marketing Partner
WORCESTER, Mass., Dec. 13, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has received a $400,000 purchase order for the Company's over-the-counter products, including Glucose Rapid Spray(tm), from Leosons General Trading Company ("Leosons"), its Marketing and Distribution Partner in the Middle East.